A prodrug form of mycophenolic acid
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Mycophenolate Mofetil

Item No. 13988

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4E-hexenoic acid, 2-(4-morpholinyl)ethyl ester
CAS Number
128794-94-5
Synonyms
  • MMF
  • RS 61443
Molecular Formula
C23H31NO7
Formula Weight
433.5
Purity
≥95%
Formulation (Request formulation change)
A crystalline solid
Solubility(Learn about Variance in Solubility)
DMF: 14 mg/mlDMF:PBS (pH 7.2) (1:1): 0.5 mg/mlDMSO: 10 mg/mlEthanol: 1.4 mg/ml
λmax
215, 249, 305 nm
SMILES
O=C(OC1)C2=C1C(C)=C(OC)C(C/C=C(C)/CCC(OCCN3CCOCC3)=O)=C2O
InChi Code
InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+
InChi Key
RTGDFNSFWBGLEC-SYZQJQIISA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    50 mg

    $50

    Add

    100 mg

    $94

    Add

    250 mg

    $218

    Add

    500 mg

    $387

    Add
    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Mycophenolate mofetil is a prodrug form of mycophenolic acid (Item No. 21716).1,2,3 It is converted to mycophenolic acid via carboxylesterase 1 (CES1) and CES2.4 Mycophenolate mofetil (1 and 10 µg/ml) inhibits thymidine incorporation in primary rat aortic smooth muscle cells.5 In vivo, mycophenolate mofetil (12.5 mg/kg) increases the duration of transplant motor activity in a rabbit model of retroperitoneal heterotopic heart transplantation.1 It eliminates formation of microbleeds and hemorrhages in the cerebrum of stroke-prone spontaneously hypertensive rats when administered at a dose of 25 mg/kg.2 Mycophenolate mofetil (60 mg/kg) also lowers mean arterial pressure (MAP) and reduces urinary albumin excretion and glomerulosclerosis, markers of renal damage, in a mouse model of systemic lupus erythematosus (SLE).3 Formulations containing mycophenolate mofetil have been used in the prophylaxis of organ rejection.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Aygün, F., Efe, D., and Durgut, K. Comparison of MMF with prednisone in terms of rejection and duration of activity of transplant in rabbits that underwent retroperitoneal heterotopic heart transplantation. Cardiovasc. J. Afr. 26(3), 104-108 (2015).

    2. Dhande, I.S., Zhu, Y., Braun, M.C., et al. Mycophenolate mofetil prevents cerebrovascular injury in stroke-prone spontaneously hypertensive rats. Physiol. Genomics 49(3), 132-140 (2017).

    3. Taylor, E.B., and Ryan, M.J. Immunosuppression with mycophenolate mofetil attenuates hypertension in an experimental model of autoimmune disease. J. Am. Heart Assoc. 6(3), e005394 (2017).

    4. Fujiyama, N., Miura, M., Kato, S., et al. Involvement of carboxylesterase 1 and 2 in the hydrolysis of mycophenolate mofetil. Drug Metab. Dispos. 38(12), 2210-2217 (2010).

    5. Räisänen-Sokolowski, A., Vuoristo, P., Myllärniemi, M., et al. Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts. Transpl. Immunol. 3(4), 342-351 (1995).